https://gabionline.net/biosimilars/news/celltrion-advances-for-yuflyma-and-vegzelma-biosimilars
Celltrion: advances for Yuflyma and Vegzelma biosimilars
In the first half of 2023, South-Korea based Celltrion Biologics announced the approval of their Yuflyma (adalimumab-aaty) biosimilar in the US, th...
celltrionadvancesyuflymavegzelmabiosimilars